A bimodal model of the mechanism of action of lithium

Molecular Psychiatry

Volumn 4, Issue 1, 1999, Pages 21-25

  Jope, R S ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

AP 1; Bipolar disorder; Carbamazepine; Cyclic AMP; Lithium; Valproate

Indexed keywords

CYCLIC AMP; DNA; LITHIUM; TRANSCRIPTION FACTOR AP 1;

ARTICLE; DRUG MECHANISM; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; MODEL; PRIORITY JOURNAL; PROTEIN DNA BINDING; SIGNAL TRANSDUCTION;

EID: 0033013011     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000444     Document Type: Article

References (35)

1. 1 Mork A, Geisler A, Hollund P. Effects of lithium on second messenger systems in the brain. Pharmacol Toxicol 1992; 71: 4-17.
2. 2 Manji HK, Lenox RH. Long-term action of lithium: a role for transcriptional and posttranscriptional factors regulated by protein kinase C. Synapse 1994; 16: 11-28.
3. 3 Jope RS, Williams MB. Lithium and brain signal transduction systems. Biochem Pharmacol 1994; 47: 429-441.
4. 4 Williams MB, Jope RS. Circadian variation in rat brain AP-1 DNA binding activity after cholinergic stimulation: modulation by lithium. Psychopharmacology 1995; 122: 363-368.
5. 5 Morgan JI, Curran T. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu Rev Neurosci 1991; 14: 421-451.
6. 6 Unlap MT, Jope RS. Lithium attenuates nerve growth factor-induced activation of AP-1 DNA binding activity in PC12 cells. Neuropsychopharmacology 1997; 17: 12-17.
7. 7 Jope RS, Song L. AP-1 and NF-κB stimulated by carbachol in human neuroblastoma SH-SY5Y cells are differentially sensitive to inhibition by lithium. Mol Brain Res 1997; 50: 171-180.
8. 8 Ozaki N, Chuang D-M. Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain. J Neurochem 1997; 69: 2336-2344.
9. 9 Chen G, Yuan P, Hawver DB, Potter WZ, Manji HK. Increase in AP-1 transcription factor DNA binding activity by valproic acid. Neuropsychopharmacology 1997; 16: 238-245.
10. 10 Yuan P-X, Chen G, Huang L-D, Manji HK. Lithium stimulates gene expression through the AP-1 transcription factor pathway. Mol Brain Res 1998; (in press).
11. 11 Avissar S, Schreiber G, Danon A, Belmaker RH. Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature 1988; 331: 440-442.
12. 12 Song L, Jope RS. Chronic lithium treatment impairs phosphatidyl-inositol hydrolysis in membranes from rat brain regions. J Neurochem 1992; 58: 2200-2206.
13. 13 Nahorski SR, Ragan CI, Challiss RA. Lithium and the phosphoinositide cycle: an example of uncompetitive inhibition and its pharmacological consequences. Trends Pharmacol Sci 1991; 12: 297-303.
14. 14 Atack JR. Inositol monophosphatase, the putative therapeutic target for lithium. Brain Res Rev 1996; 22: 183-190.
15. 15 Belmaker RH, Bersudsky Y, Agam G, Levine J, Kofman O. How does lithium work on manic depression? Clinical and psychological correlates of the inositol theory. Annu Rev Med 1996; 47: 47-56.
16. 16 Wang H-Y, Friedman E. Lithium inhibition of protein kinase C activation-induced serotonin release. Psychopharmacology 1989; 99: 213-218.
17. 17 Li PP, Sibony D, Green MA, Warsh JJ. Lithium modulation of phosphoinositide signaling system in rat cortex: selective effect on phorbol ester binding. J Neurochem 1993; 61: 1722-1730.
18. 18 Manji HK, Etchberrigaray R, Chen G, Olds JL. Lithium decreases membrane-associated protein kinase C in hippocampus: selectivity for the n isozyme. J Neurochem 1993; 61: 2303-2310.
19. 19 Watson DG, Lenox RH. Chronic lithium-induced down-regulation of MARCKS in immortalized hippocampal cells: potentiation by muscarinic receptor activation. J Neurochem 1996; 67: 767-777.
20. 20 Klein PS, Melton DA. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 1996; 93: 8455-8459.
21. 21 Stambolic V, Ruel L, Woodgett JR. Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cells. Current Biol 1996; 6: 1664-1668.
22. 22 Plyte SE, Hughes K, Nikolakaki E, Pulverer BJ, Woodgett JR. Glycogen synthase kinase-3: functions in oncogenesis and development. Biochim Biophys Acta 1992; 1114: 147-162.
23. 23 Gilman AG. G proteins: transducers of receptor-generated signals. Ann Rev Biochem 1987; 56: 615-649.
24. 24 Manji HK. G proteins: implications for psychiatry. Am J Psychiatry 1992; 149: 1-15.
25. 25 Hudson CJ, Young LT, Li PP, Warsh JJ. CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia. Synapse 1993; 13: 278-293.
26. 26 Hsiao JK, Manji HK, Chen G, Bitran JA, Risby ED, Potter WZ. Lithium administration modulates platelet G, in humans. Life Sci 1991; 50: 227-233.
27. 27 Masana MI, Bitran JA, Hsiao JK, Potter WZ. In vivo evidence that lithium inactivates Gi modulation of adenylate cyclase in brain. J Neurochem 1992; 59: 200-205.
28. 28 Lewin E, Bleck V. Cyclic AMP accumulation in cerebral cortical slices: effect of carbamazepine, phenobarbital, and phenytoin. Epilepsia 1977; 18: 237-242.
29. 29 Van Calker D, Steber R, Klotz KN, Greil W. Carbamazepine distinguishes between adenosine receptors that mediate different second messenger responses. Eur J Pharmacol 1991; 206: 285-290.
30. 30 Chen G, Pan B, Hawver DB, Wright CB, Potter WZ, Manji HK. Attenuation of cyclic AMP production by carbamazepine. J Neurochem 1996; 67: 2079-2086.
31. 31 Lee KAW, Masson N. Transcriptional regulation by CREB and its relatives. Biochim Biophys Acta 1993; 1174: 221-233.
32. 32 Abel T, Martin KC, Bartsch D, Kandel ER. Memory suppressor genes: inhibitory constraints on the storage of long-term memory. Science 1998; 279: 338-341.
33. 33 Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997; 54: 597-606.
34. 34 Elkis H, Friedman L, Wise A, Meltzer HY. Meta-analysis of studies of ventricular enlargement and cortical sulcal prominence in mood disorders. Arch Gen Psychiatry 1995; 52: 735-746.
35. 35 Sheline YI, Wany P, Gado MH, Czernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 1996; 93: 3908-3913.